Skip to content

Study on the Administration of GLP-1 Receptor Agonists and SGLT2 Inhibitors in Non-Diabetic Obese Patients

Research on the Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for the Treatment and Prevention of Obesity and Overweight in Non-Diabetic Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1051240189
Enrollment
Unknown
Registered
2024-11-18
Start date
2024-11-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

None listed

Sponsors

Takashi Hirayama
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: **Patient Selection Criteria** **Eligibility Criteria:** 1. Individuals who did not achieve satisfactory results with standard treatments for obesity and overweight in non-diabetic patients. 2. Individuals who prefer not to undergo standard pharmacological treatments due to concerns about side effects or other reasons. **Application Criteria:** 1. Individuals with HbA1c levels of 6.4% or below. 2. Individuals with a BMI of 25 or higher. 3. Individuals aged 18 years or older. 4. Individuals with the capacity to provide informed consent. 5. Individuals who receive a detailed explanation of the treatment, along with the consent form, and provide written consent of their own free will. 6. Individuals whose attending physician deems the treatment necessary.

Exclusion criteria

Exclusion criteria: " Individuals meeting any of the following conditions will be excluded from the study: 1. Users of narcotics or stimulants. 2. Individuals deemed inappropriate by the attending physician"

Design outcomes

Primary

MeasureTime frame
Body Weight BMI: Body Mass Index (BMI) Body Fat Percentage

Secondary

MeasureTime frame
subjective symptoms, etc.

Contacts

Public ContactHirayama Takashi

OSAKA UMEDA KENBI CLINIC

hirayama@gents-clinic.com+81-6-6110-5665

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026